Last reviewed · How we verify

NCT05450393

Data Collection of PillCamTM SB3 Capsule Endoscopy and Device-Assisted Enteroscopy Routine Care Procedures (GPS Study)

Withdrawn Last updated 19 August 2024
What this trial tests

trial in Small Intestine Disease. Withdrawn.

Timeline
1 May 2024
Primary endpoint
30 April 2026
30 April 2026

Quick facts

Lead sponsorMedtronic - MITG
StatusWithdrawn
Study typeOBSERVATIONAL
Start date1 May 2024
Primary completion30 April 2026
Estimated completion30 April 2026

Conditions studied

Sponsor

Medtronic - MITG — full company profile →

Who can join

18 and older, any sex, with Small Intestine Disease or Small Intestine Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A prospective, multicenter, post-market, minimal risk, observational study designed to collect PillCamTM SB3 capsule endoscopy (CE) procedures and subsequent device-assisted enteroscopy (DAE) procedures data (double balloon enteroscopy (DBE), single balloon enteroscopy (SBE) and spiral enteroscopy (SE)) in medical centers in the United States (US).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Small Intestine Disease

Currently open trials in the same condition.

Other Medtronic - MITG trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05450393.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing